Transglutaminase Activity as a Possible Therapeutical Target in Neurodegenerative Diseases

Publisher： Bentham Science Publishers

E-ISSN： 2212-3954|8|3|235-242

ISSN： 1574-8898

Source： Recent Patents on CNS Drug Discovery, Vol.8, Iss.3, 2013-01, pp. : 235-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transglutaminase Inhibition as a Possible Therapeutical Approach to Protect Cells from Death in Neurodegenerative Diseases

By  

Recent Patents on CNS Drug Discovery, Vol. 8, Iss. 2, 2013-08 ,pp. : 161-168

Bentham Science Publishers

Access to resources Recommend Favorite

Possible Physiopathological Roles of the Transglutaminase Activity in the Etiopathogenesis of Human Neurodegenerative Diseases

By  

Recent Patents on CNS Drug Discovery, Vol. 9, Iss. 2, 2014-08 ,pp. : 101-109

Bentham Science Publishers

Access to resources Recommend Favorite

Possible Physiopathological Effects of the Transglutaminase Activity on the Molecular Mechanisms Responsible for Human Neurodegenerative Diseases

By  

Recent Patents on CNS Drug Discovery, Vol. 9, Iss. 2, 2014-08 ,pp. : 76-84

Bentham Science Publishers

Access to resources Recommend Favorite

The Neuronal Cytoskeleton as a Potential Therapeutical Target in Neurodegenerative Diseases and Schizophrenia

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 6, 2004-01 ,pp. : 515-533

Bentham Science Publishers

Access to resources Recommend Favorite

Role of the Transglutaminase Enzymes in the Nervous System and their Possible Involvement in Neurodegenerative Diseases

By  

Current Medicinal Chemistry, Vol. 16, Iss. 36, 2009-12 ,pp. : 4767-4773

Bentham Science Publishers

Access to resources Recommend Favorite